The Promising role of Chemo-Immunotherapy in Non-Small Cell Lung Cancer Neoadjuvant Setting

被引：0
|
作者：
Bote, H. [1 ]
Modrego, A. [1 ]
Jimenez-Aguilar, E. [1 ]
Mazarico, J. M. [1 ]
Nunez-Sobrino, J. A. [1 ]
Iglesias, L. C. [1 ]
Baena, J. [1 ]
Zugazagoitia, J. [1 ]
Ponce-Aix, S. [1 ]
Paz-Ares, L. [1 ]
机构：
[1] Univ Hosp 12 Octubre, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Neoadjuvant; Unresectable NSCLC; chemo-immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P21.14
引用
收藏
页码：S369 / S370
页数：2
相关论文
共 50 条
  • [1] The Role of Neoadjuvant Chemo-Immunotherapy in Unresectable Non-Small Cell Lung Cancer
    Oh, M.
    Davis, A.
    Lentz, R.
    Peterman, N.
    Robertson, A.
    Srivas, R.
    Lambert, N.
    Wilson, T.
    Tezcan, H.
    Bharat, A.
    Chae, Y. K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S947 - S948
  • [2] The role of combination chemo-immunotherapy in advanced non-small cell lung cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Battiloro, Ciro
    Gridelli, Cesare
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 561 - 568
  • [3] Chemo-immunotherapy A new option for non-small cell lung cancer
    Vitale, Giovanni
    Abbruzzese, Alberto
    Tonini, Giuseppe
    Santini, Daniele
    [J]. CANCER BIOLOGY & THERAPY, 2009, 8 (06) : 503 - 504
  • [4] Efficacy and biomarker identification of neoadjuvant chemo-immunotherapy in potentially resectable non-small cell lung cancer
    Zhang, Y.
    Zeng, L.
    Zhang, X.
    Zhou, Y.
    Zhang, B.
    Guo, L.
    Guan, Y.
    Gao, X.
    Wang, H.
    Xia, X.
    Zhou, C.
    Yang, N.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S934 - S934
  • [5] The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy
    Zattarin, E.
    Manglaviti, S.
    Galli, E.
    Apollonio, G.
    Beninato, T.
    Mazzeo, L.
    Massa, G.
    Bottiglieri, A.
    Ganzinelli, M.
    Proto, C.
    Ferrara, R.
    Prelaj, A.
    Galli, G.
    De Toma, A.
    Brambilla, M.
    Occhipinti, M.
    Garassino, M. C. C.
    De Braud, F. G. M.
    Lo Russo, G.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1010 - S1011
  • [6] Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?
    Casaluce, Francesca
    Gridelli, Cesare
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (02) : 121 - 127
  • [7] Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study
    Wang, Xun
    Wang, Xin
    Hui, Bengang
    Cai, Jingsheng
    Zhao, Heng
    Qiao, Bowei
    Duan, Jiangnan
    Chen, Kezhong
    Wang, Jun
    Lei, Jie
    Yang, Fan
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04)
  • [8] Evaluation of neoadjuvant chemo-immunotherapy for operable non-small cell lung cancer: clinical outcomes and impact on service delivery
    Taher, Abu
    John, Alexius
    Rehman, Faisal
    Milner-Watts, Charlotte
    McMahon, David
    Manickavasagar, Thubeena
    Cartwright, Elizabeth
    Yousaf, Nadia
    Gil, Cano Domingo Vicente
    Tan, Carol
    Smelt, Jeremy
    Hunt, Ian
    Jordan, Simon
    Begum, Sofina
    Bhosle, Jaishree
    Minchom, Anna
    Tokaca, Nadza
    Popat, Sanjay
    O'Brien, Mary
    Davidson, Michael
    [J]. LUNG CANCER, 2024, 190
  • [9] Neoadjuvant Chemo-Immunotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Review of the Literature
    Franzi, Sara
    Mattioni, Giovanni
    Rijavec, Erika
    Croci, Giorgio Alberto
    Tosi, Davide
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [10] Metabolomics profiling in prediction of chemo-immunotherapy efficiency in advanced non-small cell lung cancer
    Mei, Lihong
    Zhang, Zhihua
    Li, Xushuo
    Yang, Ying
    Qi, Ruixue
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
12345